ClinicalTrials.gov
ClinicalTrials.gov Menu

Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk (TIERRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00874185
Recruitment Status : Completed
First Posted : April 2, 2009
Last Update Posted : February 13, 2013
Sponsor:
Information provided by (Responsible Party):
Pfizer

Brief Summary:
Evaluate satisfaction in people treated with IPDE5 inhibitors over time

Condition or disease
Erectile Dysfunction

Detailed Description:
12 first patients that are eligible

Study Type : Observational
Actual Enrollment : 720 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Satisfaction With Treatment In Patients With Erectile Dysfunction And Cardiovascular Risk And/Or Previous Cardiovascular Event.
Study Start Date : December 2007
Actual Primary Completion Date : May 2008
Actual Study Completion Date : May 2008

Resource links provided by the National Library of Medicine


Group/Cohort
Questionnaire
filling in questionnaires



Primary Outcome Measures :
  1. EDITS [ Time Frame: 6 months ]
  2. SEAR [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Medication prescribed [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
People with cv risk
Criteria

Inclusion Criteria:

  • CV risk factors
  • Male above 18

Exclusion Criteria:

  • Non-informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00874185


Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer

Additional Information:
Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT00874185     History of Changes
Other Study ID Numbers: A1481256
A1481256
First Posted: April 2, 2009    Key Record Dates
Last Update Posted: February 13, 2013
Last Verified: February 2013

Keywords provided by Pfizer:
satisfaction

Additional relevant MeSH terms:
Erectile Dysfunction
Sexual Dysfunction, Physiological
Genital Diseases, Male
Sexual Dysfunctions, Psychological
Mental Disorders
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action